Ferro, J. M., & Nagel, S. (2019). Safety and efficacy of Dabigatran etexilate vs dose-adjusted warfarin in patients with cerebral venous thrombosis: A randomized clinical trial. JAMA neurology, 76(12), . https://doi.org/10.1001/jamaneurol.2019.2764
Chicago-Zitierstil (17. Ausg.)Ferro, José M., und Simon Nagel. "Safety and Efficacy of Dabigatran Etexilate Vs Dose-adjusted Warfarin in Patients with Cerebral Venous Thrombosis: A Randomized Clinical Trial." JAMA Neurology 76, no. 12 (2019). https://doi.org/10.1001/jamaneurol.2019.2764.
MLA-Zitierstil (9. Ausg.)Ferro, José M., und Simon Nagel. "Safety and Efficacy of Dabigatran Etexilate Vs Dose-adjusted Warfarin in Patients with Cerebral Venous Thrombosis: A Randomized Clinical Trial." JAMA Neurology, vol. 76, no. 12, 2019, https://doi.org/10.1001/jamaneurol.2019.2764.